262 related articles for article (PubMed ID: 9915850)
1. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
Slavik JM; Hutchcroft JE; Bierer BE
J Biol Chem; 1999 Jan; 274(5):3116-24. PubMed ID: 9915850
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.
Hutchcroft JE; Slavik JM; Lin H; Watanabe T; Bierer BE
J Immunol; 1998 Nov; 161(9):4506-12. PubMed ID: 9794375
[TBL] [Abstract][Full Text] [Related]
3. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
[TBL] [Abstract][Full Text] [Related]
4. CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86.
Cefai D; Cai YC; Hu H; Rudd C
Int Immunol; 1996 Oct; 8(10):1609-16. PubMed ID: 8921441
[TBL] [Abstract][Full Text] [Related]
5. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation.
Skapenko A; Lipsky PE; Kraetsch HG; Kalden JR; Schulze-Koops H
J Immunol; 2001 Apr; 166(7):4283-92. PubMed ID: 11254680
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.
Irvin BJ; Williams BL; Nilson AE; Maynor HO; Abraham RT
Mol Cell Biol; 2000 Dec; 20(24):9149-61. PubMed ID: 11094067
[TBL] [Abstract][Full Text] [Related]
8. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
[TBL] [Abstract][Full Text] [Related]
9. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro.
Levine BL; Ueda Y; Craighead N; Huang ML; June CH
Int Immunol; 1995 Jun; 7(6):891-904. PubMed ID: 7577797
[TBL] [Abstract][Full Text] [Related]
10. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities.
Michel F; Attal-Bonnefoy G; Mangino G; Mise-Omata S; Acuto O
Immunity; 2001 Dec; 15(6):935-45. PubMed ID: 11754815
[TBL] [Abstract][Full Text] [Related]
11. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
12. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
[TBL] [Abstract][Full Text] [Related]
13. Biased dependency of CD80 versus CD86 in the induction of transcription factors regulating the human IL-2 promoter.
Olsson C; Michaëlsson E; Parra E; Pettersson U; Lando PA; Dohlsten M
Int Immunol; 1998 Apr; 10(4):499-506. PubMed ID: 9620606
[TBL] [Abstract][Full Text] [Related]
14. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
15. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
16. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
17. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.
Vandenberghe P; Freeman GJ; Nadler LM; Fletcher MC; Kamoun M; Turka LA; Ledbetter JA; Thompson CB; June CH
J Exp Med; 1992 Apr; 175(4):951-60. PubMed ID: 1372649
[TBL] [Abstract][Full Text] [Related]
18. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
[TBL] [Abstract][Full Text] [Related]
19. Effect of CD80 and CD86 on T cell cytokine production.
Petro TM; Chen SS; Panther RB
Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
[TBL] [Abstract][Full Text] [Related]
20. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
